HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amyris Looks To Personal Care As Growth Engine For Renewable Ingredients

This article was originally published in The Rose Sheet

Executive Summary

Sustainable ingredients being developed by Emeryville, Calif.-based biotech Amyris Inc. have piqued the interest of big players in the personal-care and fragrance industries.

You may also be interested in...

Amyris Moving 30 Molecules Through R&D Pipeline, Streamlining Consumer Portfolio

Amyris, Inc. is developing 30 molecules using its bio-fermentation technology, negotiating a bio-manufacturing joint venture that could yield $50m-$100m in proceeds, and simplifying its Consumer portfolio to unlock value. Cost containment and liquidity will continue to be key priorities for the synthetic biotech firm while it targets up to 100% revenue growth in fiscal 2023.

Givaudan Strikes Deal For Amyris Ingredients, Long-Term Partnership

The deal has Amyris selling three key cosmetic ingredients to Givaudan and producing more biotech ingredients for the Swiss firm over the long term. “In the future, we will continue to push the boundaries of biotech, creating new sustainable innovations for a better beauty future,” says Givaudan’s Maurizio Volpi, president, Fragrance and Beauty.

Renewable Ingredient Firm Signs Givaudan, Boasts $10 Mil. "Pipeline Of Interest"

Renewable ingredients supplier Amyris is positioning itself as a go-to player in the sustainable cosmetics arena, projecting nearly $10 million in potential sales of cosmetic emollient squalane and announcing a new deal with Swiss fragrance house Givaudan.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts